Case Study
DeltaVSystem Pilot Project Leads to Automation Update for Eli Lilly Recombinant DNA Product
LIFE SCIENCES DeltaV TM System Pilot Project Leads to Automation Update for Eli Lilly Recombinant DNA Product RESULTS ?Reduced first loop engineering cost by magnitude of 10 ?Reduced training time ?25% reduced configuration time ?50% reduced system installation and check out time ?Reduced implementation time ?Reduced validation time/cost APPLICATION Batch pharmaceutical bacterial fermentation CUSTOMER Eli Lilly and Company. In 1982, Lilly’s Humulin product (biosynthetic human insulin) became the first pharmaceutical product in the world made by bacteria genetically engineered through recombinant DNA technology. Other well-known Lilly pharmaceuticals include the antidepressant Prozac and the antibiotics Ceclor (cefaclor) and Vancocin (vancomycin hydrochloride). As a point of histor